Stefano Fontana

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


40 publications

2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2006 | 2005 | 2004 | 2001 | 1994 |
Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016
Niederhauser Christoph, Widmer Nadja, Hotz Magdalena, Tinguely Caroline, Fontana Stefano, Allemann Gabrielle, Borri Mauro, Infanti Laura, Sarraj Amira, Sigle Jörg et al., 2018/08/30. Eurosurveillance, 23 (35).
 
Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens.
Reckhaus J., Jutzi M., Fontana S., Bacher V.U., Vogt M., Daslakis M., Mansouri Taleghani B., 2018/05. Transfusion medicine and hemotherapy, 45 (3) pp. 167-172. Peer-reviewed.
Editorial: Transfusion Medicine and Blood.
Prudent M., Tissot J.D., Fontana S., Niederhauser C., 2018. Frontiers in medicine, 5 p. 355. Peer-reviewed.
 
Red blood cell use in Switzerland: trends and demographic challenges.
Volken T., Buser A., Castelli D., Fontana S., Frey B.M., Rüsges-Wolter I., Sarraj A., Sigle J., Thierbach J., Weingand T. et al., 2018/01. Blood transfusion = Trasfusione del sangue, 16 (1) pp. 73-82. Peer-reviewed.
 
West Nile Virus preparedness plan to ensure safe blood components in Switzerland: a risk-based approach
Niederhauser C., Fontana S., Glauser A., Steinemann C., Koller A., 2017/05. ISBT Science Series, 12 (2) pp. 314-321.
 
Generalizability of Dutch Prediction Models for Low Hemoglobin Deferral: A Study on External Validation and Updating in Swiss Whole Blood Donors.
Baart A.M., Fontana S., Tschaggelar A., Heymans M.W., de Kort W.L., 2016/11. Transfusion medicine and hemotherapy, 43 (6) pp. 407-414. Peer-reviewed.
 
Too Many Blood Donors - Response Bias in the Swiss Health Survey 2012.
Volken T., Bänziger A., Buser A., Castelli D., Fontana S., Frey B.M., Sarraj A., Sigle J., Thierbach J., Weingand T. et al., 2016/11. Transfusion medicine and hemotherapy, 43 (6) pp. 400-406. Peer-reviewed.
 
Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet Concentrate
Gowland Peter, Fontana Stefano, Stolz Martin, Andina Nicola, Niederhauser Christoph, 2016. Transfusion Medicine and Hemotherapy, 43 (3) pp. 198-202.
 
Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio.
Sistonen J., Büchel B., Froehlich T.K., Kummer D., Fontana S., Joerger M., van Kuilenburg A.B., Largiadèr C.R., 2014/09. Pharmacogenomics, 15 (13) pp. 1653-1666. Peer-reviewed.
 
A Simple Guideline Reduces the Need for Red Blood Cell Transfusions in Swiss Hospitals: A Prospective, Multicentre, Before-and-After Study in Elective Hip and Knee Replacement.
Fontana S., de la Cuadra C., Müller U., Schmid P., Perler M., Luginbühl M., Taleghani B.M., 2014. Transfusion Medicine and Hemotherapy, 41 (3) pp. 182-188. Peer-reviewed.
 
Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.
Adam J., Wuillemin N., Watkins S., Jamin H., Eriksson K.K., Villiger P., Fontana S., Pichler W.J., Yerly D., 2014. Plos One, 9 (4) pp. e95339. Peer-reviewed.
 
Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
Stolz M., Tinguely C., Fontana S., Niederhauser C., 2014. Transfusion, 54 (11) pp. 2961-2967. Peer-reviewed.
 
Implementation of a mandatory donor RHD screening in Switzerland.
Crottet S.L., Henny C., Meyer S., Still F., Stolz M., Gottschalk J., Neuenschwander K., Taleghani B.M., Gowland P., Frey B.M. et al., 2014. Transfusion and Apheresis Science, 50 (2) pp. 169-174. Peer-reviewed.
 
Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors.
Gowland P., Gassner C., Hustinx H., Stolz M., Gottschalk J., Tissot J.D., Thierbach J., Maier A., Sigurdardottir S., Still F. et al., 2014. Transfusion and Apheresis Science, 50 (2) pp. 163-168. Peer-reviewed.
 
Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01.
Yun J., Marcaida M.J., Eriksson K.K., Jamin H., Fontana S., Pichler W.J., Yerly D., 2014. Journal of Immunology, 192 (7) pp. 2984-2993. Peer-reviewed.
 
T cells infiltrate the liver and kill hepatocytes in HLA-B(∗)57:01-associated floxacillin-induced liver injury.
Wuillemin N., Terracciano L., Beltraminelli H., Schlapbach C., Fontana S., Krähenbühl S., Pichler W.J., Yerly D., 2014. American Journal of Pathology, 184 (6) pp. 1677-1682. Peer-reviewed.
 
Transfusion efficacy of apheresis platelet concentrates irradiated at the day of transfusion is significantly superior compared to platelets irradiated in advance.
Julmy F., Ammann R.A., Fontana S., Taleghani B.M., Hirt A., Leibundgut K., 2014. Transfusion Medicine and Hemotherapy, 41 (3) pp. 176-181. Peer-reviewed.
 
Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
Yun J., Mattsson J., Schnyder K., Fontana S., Largiadèr C.R., Pichler W.J., Yerly D., 2013. Clinical and Experimental Allergy, 43 (11) pp. 1246-1255. Peer-reviewed.
 
Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
Sigle J.P., Thierbach J., Infanti L., Muriset M., Hunziker G., Chassot K., Niederhauser C., Gowland P., Holbro A., Sunic K. et al., 2013. Vox Sanguinis, 105 (3) pp. 244-252. Peer-reviewed.
 
HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin.
Wuillemin N., Adam J., Fontana S., Krähenbühl S., Pichler W.J., Yerly D., 2013. Journal of Immunology, 190 (10) pp. 4956-4964. Peer-reviewed.
 
Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA.
Lejon Crottet S., Haer-Wigman L., Gowland P., Fontana S., Niederhauser C., Hustinx H., 2013. Transfusion, 53 (11 Suppl 2) pp. 3000-3008. Peer-reviewed.
 
Seroprevalence of hantavirus infections in Switzerland in 2009: difficulties in determining prevalence in a country with low endemicity.
Engler O., Klingstrom J., Aliyev E., Niederhauser C., Fontana S., Strasser M., Portmann J., Signer J., Bankoul S., Frey F. et al., 2013. Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 18 (50) p. 20660.
 
Avidity determines T-cell reactivity in abacavir hypersensitivity.
Adam J., Eriksson K.K., Schnyder B., Fontana S., Pichler W.J., Yerly D., 2012. European Journal of Immunology, 42 (7) pp. 1706-1716. Peer-reviewed.
 
Platelet Recruitment during Multiple Donor Platelet Apheresis Differs between Cell Separators.
Fontana S., Keller P., Taleghani B.M., 2011. Transfusion Medicine and Hemotherapy, 38 (3) pp. 195-198. Peer-reviewed.
 
Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
Fontana S., Rados L., Schmid P., Leibundgut E.O., Taleghani B.M., 2011. Transfusion, 51 (9) pp. 2034-2043. Peer-reviewed.
 
500 ml of blood loss does not decrease non-invasive tissue oxygen saturation (StO2) as measured by near infrared spectroscopy - A hypothesis generating pilot study in healthy adult women.
Jeger V., Jakob S.M., Fontana S., Wolf M., Zimmermann H., Exadaktylos A.K., 2010. Journal of Trauma Management and Outcomes, 4 p. 5. Peer-reviewed.
 
Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region.
Stolz M., Tinguely C., Graziani M., Fontana S., Gowland P., Buser A., Michel M., Canellini G., Züger M., Schumacher P. et al., 2010. Transfusion, 50 (12) pp. 2695-2706. Peer-reviewed.
 
Molecular basis of the Rh antigen RH48 (JAL).
Hustinx H., Poole J., Bugert P., Gowland P., Still F., Fontana S., Scharberg E.A., Tilley L., Daniels G., Niederhauser C., 2009. Vox Sanguinis, 96 (3) pp. 234-239. Peer-reviewed.
 
Prospective, Paired Crossover Comparison of the in vitro Quality of Red Blood Cells Collected by the Automate for Blood Collection Device or by a Conventional Method.
Fontana S., Weingand T., Maier A., Taleghani B.M., 2009. Transfusion Medicine and Hemotherapy, 36 (4) pp. 289-292. Peer-reviewed.
 
Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
Julmy F., Ammann R.A., Taleghani B.M., Fontana S., Hirt A., Leibundgut K., 2009. Transfusion, 49 (1) pp. 21-33. Peer-reviewed.
 
Effects of high-yield thrombocytapheresis on the quality of platelet products.
Julmy F., Ammann R.A., Mansouri Taleghani B., Fontana S., Hirt A., Leibundgut K., 2008. Transfusion, 48 (3) pp. 442-450. Peer-reviewed.
 
Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency.
Fontana S., Groebli R., Leibundgut K., Pabst T., Zwicky C., Taleghani B.M., 2006. Transfusion, 46 (8) pp. 1408-1416. Peer-reviewed.
 
Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
Fontana S., Mordasini L., Keller P., Taleghani B.M., 2006. Transfusion, 46 (11) pp. 2004-2010. Peer-reviewed.
 
Oxaliplatin-induced immune pancytopenia.
Taleghani B.M., Meyer O., Fontana S., Ahrens N., Novak U., Borner M.M., Salama A., 2005. Transfusion, 45 (5) pp. 704-708. Peer-reviewed.
 
Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis.
Zahnd D., Leibundgut K., Zenhäusern R., Pabst T., Fontana S., Schneider R., Tobler A., Zwicky C., 2004. Bone Marrow Transplantation, 34 (10) pp. 847-853. Peer-reviewed.
 
Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus.
Gowland P., Fontana S., Niederhauser C., Taleghani B.M., 2004. Transfusion, 44 (11) pp. 1555-1561. Peer-reviewed.
 
Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.
Fontana S., Kremer Hovinga J.A., Studt J.D., Alberio L., Lämmle B., Taleghani B.M., 2004. Seminars in Hematology, 41 (1) pp. 48-59. Peer-reviewed.
 
Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.
Kremer Hovinga J.A., Studt J.D., Demarmels Biasiutti F., Solenthaler M., Alberio L., Zwicky C., Fontana S., Taleghani B.M., Tobler A., Lämmle B., 2004. Haematologica, 89 (3) pp. 320-324. Peer-reviewed.
 
Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.
Fontana S., Gerritsen H.E., Kremer Hovinga J., Furlan M., Lämmle B., 2001. British Journal of Haematology, 113 (1) pp. 100-102. Peer-reviewed.
 
Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution.
Zucca E., Fontana S., Roggero E., Pedrinis E., Pampallona S., Cavalli F., 1994. Leukemia and Lymphoma, 13 (1-2) pp. 105-110. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University